Patent details

Basic Information

Publication number:

EP2283825

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP100119387

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Enteric solid oral dosage form of a bisphosphonate containing a chelating agent

French Title of Invention:

Formes orales entériques solides de dosage d'un diphosphonate avec un agent chélatant

German Title of Invention:

Enterische feste orale Dosierform eines Bisphosphonats mit einem Chelate

SPC Number:

Dates

Filing date:

14/04/2005

Grant date:

13/04/2022

EP Publication Date:

16/02/2011

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

13/04/2022

EP B1 Publication Date:

13/04/2022

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

14/04/2022

Expiration date:

14/04/2025

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

06/04/2022

 

 

Name:

Theramex HQ UK Limited

Address:

Sloane Square House 1 Holbein Place, Belgravia Greater London SW1W 8NS, United Kingdom (GB)

Inventor

1

Name:

Dansereau, Richard John

Address:

United States (US)

2

Name:

Burgio, Ernest David, Jr.

Address:

United States (US)

Priority

Priority Number:

573881 P

Priority Date:

24/05/2004

Priority Country:

United States (US)

Classification

IPC classification:

A61K 9/20; A61K 31/675; A61K 31/00; A61K 9/28;

Publication

European Patent Bulletin

Issue number:

202215

Publication date:

13/04/2022

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages